Changes in inflammatory factors, oxidative stress, glucose and lipid metabolism, and insulin resistance in patients with polycystic ovary syndrome

被引:5
作者
Zhong, Peiwen [1 ]
Guan, Baoxing [1 ]
Lin, Yanting [1 ]
Zhang, Siyou [1 ]
机构
[1] Foshan First Peoples Hosp, Dept Obstet & Gynecol, Foshan 528000, Peoples R China
关键词
Inflammatory factors; Oxidative stress; Glucose and lipid metabolism; Insulin resistance; polycystic ovary syndrome; DAMAGE; WOMEN;
D O I
10.14715/cmb/2021.67.5.6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polycystic ovary syndrome (PCOS) is a common disease in women, affecting women's menstruation and significantly impacting women's physical and mental health. Studies have shown that insulin resistance has an important relationship with polycystic ovary. It is of great significance to explore the changes of inflammatory factors, oxidative stress, glucose and lipid metabolism, and insulin resistance in patients with PCOS. In the study process, 642 polycystic ovary patients in the first half of 2019 were divided into insulin resistance (n=357) and non-insulin resistance (n=285) groups. Oxidative stress index, glucose, and lipid metabolism index, and inflammatory factors were detected during the study process. The results showed that the levels of hs-CRP, TNF-alpha, and IL-6 in the IR group were 5.9mg/L, 9.2 mu g/L, and 87.2ng /ml, while those in the non-IR group were 4.6mg/L, 6.3 mu g/L and 51.5ng/ml, respectively. Thus, IL-6 and insulin levels maintain a dynamic balance. Low levels of IL-6 can promote insulin secretion, while high levels can inhibit its secretion. The results of this study will provide a specific clinical reference value for the prevention and treatment of polycystic ovary syndrome. Copyright: (C) 2021 by the C.M.B. Association. All rights reserved.
引用
收藏
页码:45 / 50
页数:6
相关论文
共 50 条
  • [21] Quercetin Decreases Insulin Resistance in a Polycystic Ovary Syndrome Rat Model by Improving Inflammatory Microenvironment
    Wang, Zhenzhi
    Zhai, Dongxia
    Zhang, Danying
    Bai, Lingling
    Yao, Ruipin
    Yu, Jin
    Cheng, Wen
    Yu, Chaoqin
    REPRODUCTIVE SCIENCES, 2017, 24 (05) : 682 - 690
  • [22] Upregulation of Oxidative Phosphorylation Genes in Cumulus Cells of The Polycystic Ovary Syndrome Patients with or without Insulin Resistance
    Motiee, Behnaz
    Mousavi, Seyed Omid Reza
    Eslami, Maryam
    Eftekhari-Yazdi, Poopak
    Hassani, Fatemeh
    Bazrgar, Masood
    CELL JOURNAL, 2024, 26 (04) : 235 - 242
  • [23] Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome
    Enli, Yasar
    Fenkci, Semin Melahat
    Fenkci, Veysel
    Oztekin, Ozer
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (12) : 1036 - 1039
  • [24] Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome
    Shan, Hongying
    Luo, Renxin
    Guo, Xuanying
    Li, Rong
    Ye, Zhenhong
    Peng, Tianliu
    Liu, Fenting
    Yang, Zi
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [25] Astaxanthin supplementation impact on insulin resistance, lipid profile, blood pressure, and oxidative stress in polycystic ovary syndrome patients: A triple-blind randomized clinical trial
    Jabarpour, Masoome
    Aleyasin, Ashraf
    Nashtaei, Maryam Shabani
    Amidi, Fardin
    PHYTOTHERAPY RESEARCH, 2024, 38 (01) : 321 - 330
  • [26] Polycystic ovary syndrome and insulin resistance
    Ducluzeau, PH
    Laville, M
    Vidal, H
    Pugeat, M
    DIABETES & METABOLISM, 2001, 27 (04) : S7 - S12
  • [27] Polycystic Ovary Syndrome and Insulin Resistance
    Mendoza, Nicolas
    JOURNAL OF DIABETES & METABOLISM, 2012, 4
  • [28] Insulin resistance in polycystic ovary syndrome
    Schröder, AK
    Tauchert, S
    Ortmann, O
    Diedrich, K
    Weiss, JM
    WIENER KLINISCHE WOCHENSCHRIFT, 2003, 115 (23) : 812 - 821
  • [29] Insulin resistance and polycystic ovary syndrome
    Galluzzo, Aldo
    Amato, Marco Calogero
    Giordano, Carla
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (07) : 511 - 518
  • [30] Adipose insulin resistance is associated with cardiovascular risk factors in polycystic ovary syndrome
    Mu, L.
    Li, R.
    Lai, Y.
    Zhao, Y.
    Qiao, J.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (05) : 541 - 548